panitumumab
amgen,takeda
['panitumumab', 'crcsm', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)']
patients with ras wild-type metastatic crc benefit from panitumumab/mfolfox #crcsm #asco22 #oncology 
Your online destination for Oncology Nursing news, clinical insights, and resources.